Comparison of Lithium and Haloperidol Therapy in Gilles de la Tourette Syndrome

  • H. M. EricksonJr.
  • J. E. Goggin
  • F. S. Messiha
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 90)


Three patients suffering from Gilles de la Tourette Syndrome were initially treated with haloperidol. Depressive side effects and symptom breakthrough necessitated the search for another agent. The efficacy of lithium carbonate in treating stereotyped hyperkinetic behavior (such as is seen in Gilles de la Tourette syndrome) prompted the evaluation of lithium carbonate. An objective behavior al observation technique, clinical ratings and the patient’s subjective reports were used to systematically record the response to treatment during the entire course of the study. Initially blood plasma Li+ levels in the 0.5 to 0.6 mEq/L range were obtained and these correlated with reduced frequency, as well as intensity, of involuntary motor acts (tics) and sounds. When the Li+ blood levels had stabilized at 0.8 to 0.9 mEq/L the major tics and involuntary sounds cleared dramatically.. The patients experienced no side effects and have been followed for several months without recurrence of the original symptoms.


Tourette Syndrome Corpus Striatum Target Symptom Symptom Breakthrough Haloperidol Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Balthazar, K. (1956). Ueber das anatomische Substrat der general isierten Tic-krankheit (maldie des tics, Gilles de la Tourette): Entwicklungshemmung des Corpus Striatum. Arch. psychiat. Nervekr. 195 ,531–549.CrossRefGoogle Scholar
  2. Dalen, P. (1973). Lithium therapy in Huntington’s Chorea and tardive dyskenesia. Lancet i ,107–108.CrossRefGoogle Scholar
  3. Ehringer, H. and Hornykiewicz, O. (1960). Verteilungvon Noradrenalin und Dopamine im Gehirn des Menschen und ihr verhalten be: Erkrankungen des extrapyramidalen systems. Klin. Wsch. 38 ,1236–1239.CrossRefGoogle Scholar
  4. Fernando, S.J.M. (1976). Six cases of Gilles de la Tourettefs Syndrome. Brit. J. Psychiat. 128 ,436–441.CrossRefPubMedGoogle Scholar
  5. Gilles de la Tourette, (1885). Etude sur une affection nerveuse caracterisee par de l’incordination motorice accompagnee d’echolalie et de coprolali. Arch. Peurol. (Paris) 9 ,158–200.Google Scholar
  6. Goggin, J.E. (1975). Sex differences in theactivity level of preschool children as a possible precursor of hyperactivity. J. Genet. Psychol. 127 ,75–81.CrossRefPubMedGoogle Scholar
  7. Messiha, F.S., Agallianos, D. and Clower, C. (1970). Dopamine excretion in affective states and following lithium carbonate therapy. Nature 225 ,868–869.CrossRefPubMedGoogle Scholar
  8. Messiha, F.S., Knopp, W., Vanecko, S., O’Brien, J., Corson, S. (1971). Haloperidol therapy in Tourette’s syndrome: Neurological, biochemical and behavioral correlates. Life Science 10 (1) ,449–457.CrossRefGoogle Scholar
  9. Messiha, F.S., Savage, C., Turek, I. and Hanlon, T. (1974). A psychopharmacological study of catecholamines in affective disorders. J. Nerv. Ment. Dis. 158 ,338–347.CrossRefPubMedGoogle Scholar
  10. Messiha, F. and Knopp, W. (1976). A study of endogenous dopamine metabolism in Gilles de la Tourette’s disease. Dis. Nerv. Syst. 37 ,470–473.PubMedGoogle Scholar
  11. Woodrow, K.M. (1974). Gilles de la Tourette’s disease - A review. Amer. J. Psychiatry. 131 ,1000–1003.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1977

Authors and Affiliations

  • H. M. EricksonJr.
    • 1
  • J. E. Goggin
    • 1
  • F. S. Messiha
    • 1
  1. 1.Departments of Psychiatry, Pharmacology and Therapeutics and PediatricsTexas Tech University School of MedicineLubbockUSA

Personalised recommendations